Cargando…
Vitiligo-Like Depigmentation following Treatment with Imiquimod 5% Cream for Condylomata Acuminata
Imiquimod cream is an immunomodulatory agent that has been approved by the US Food and Drug Administration for use in the treatment of anogenital warts (condylomata acuminata) due to its local immune effects in activating Toll-like receptors 7 and 8 on antigen-presenting cells, resulting in reductio...
Autores principales: | Alatabani, Maram, Ghobara, Yasser, Alissa, Ahmed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879291/ https://www.ncbi.nlm.nih.gov/pubmed/33613232 http://dx.doi.org/10.1159/000510736 |
Ejemplares similares
-
Treatment of Condylomata Acuminata Using a New Non-Vapor-Generating Focused Ultrasound Method following Imiquimod 5% Cream
por: Calik, Jacek, et al.
Publicado: (2022) -
Induction of vitiligo after imiquimod treatment of condylomata acuminata
por: Li, Wenfei, et al.
Publicado: (2014) -
Vulvar vitiligo-like depigmentation and multiple halos of hypomelanosis
at the trunk following treatment with imiquimod 5% cream for vulvar condylomata:
casual or related events?
por: Serra, Maíra Chiarelli, et al.
Publicado: (2014) -
Development of Vitiligo-Like Depigmentation after Treatment of Lentigo Maligna Melanoma with 5% Imiquimod Cream
por: Kim, Na Hee, et al.
Publicado: (2018) -
Perianal condylomata acuminata in pregnancy
por: Polychroni, Damaskini, et al.
Publicado: (2021)